Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Can AI predict which cancer drugs will actually work? Orakl Oncology raises €30 million to find out - EU-Startups
Orakl Oncology is focused on utilizing artificial intelligence to predict the effectiveness of cancer drugs. The company aims to enhance treatment outcomes for cancer patients by leveraging advanced technology in drug development.
Can AI predict which cancer drugs will actually work? Orakl Oncology raises €30 million to find out EU-Startups
You just read who funded Orakl Oncology. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.